Company profile Β· AI Β· Voice
ElevenLabs
Premium$22Bβ2Γ the Feb 2026 round ($11B)
About
ElevenLabs builds AI voice-generation and dubbing technology β synthetic speech used for audiobooks, video localization, and conversational agents. It is one of the fastest-growing generative-AI startups by revenue.
Premium or discount?
Every secondary transaction reported for ElevenLabs has priced above its prior primary round β most recently a discussed valuation roughly 2Γ its February 2026 mark β reflecting sustained buyer demand for a category leader in applied AI.
How to read this record
Two entries here, and only one of them is a completed transaction. The May 2025 event was a $100M staff sale that actually cleared, at roughly twice the January 2025 round. The 2026 entry at $22B is a reported discussion, not a closed and priced deal β sourced to press reporting rather than to a settled trade. The distinction matters: a discussed valuation is an ask, and an ask is where a process starts, not where it ends. Until a tender prices, treat the $22B as a negotiating position that a buyer pool has not yet tested.
Getting exposure from Latin America
Neither event in this record was open to outside buyers. Both were company-organised sales of employee stock, and the buy side was invited. An investor in SΓ£o Paulo or Mexico City reaching for this exposure is therefore looking at third-party routes β an SPV assembled by a broker, or a fund that already holds a position β with fees stacked at each layer and no information rights over the underlying company. In a name re-pricing this quickly, the fee drag matters less than the entry mark: paying the discussed number rather than the last cleared one is the real risk.
Secondary deal history
| Date | Valuation | vs. last round | Source |
|---|---|---|---|
| Jul 2026 | $22B | Premiumβ2Γ the Feb 2026 round ($11B) | Investing.com / Bloomberg β |
| May 2025 | $6.6B | Premium$100M staff sale, above the Jan 2025 round ($3.3B) | Citrine Capital β |
Frequently asked questions